Kim Lyerly MD

Kim Lyerly

Core Faculty

Kim Lyerly, MD


MD, University of California at Los Angeles

Hafez N, Rugo HS, Tempero MA, Fox E, Reaman GH, Lyerly HK, et al. Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting. Clin Cancer Res. 2020 Sep 15;26(18):4743–7.

Crosby EJ, Acharya CR, Haddad A-F, Rabiola CA, Lei G, Wei J-P, et al. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer. Clin Cancer Res. 2020 Sep 1;26(17):4670–81.

Trotter TN, Shuptrine CW, Tsao L-C, Marek RD, Acharya C, Wei J-P, et al. IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils. Cancer Res. 2020 Aug 1;80(15):3088–100.